Clinical use of Haemate® P in inherited von Willebrand's disease: a cohort study on 100 Italian patients | Haematologica
![PDF) One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P®/Humate P® treatment in von Willebrand disease patients PDF) One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P®/Humate P® treatment in von Willebrand disease patients](https://i1.rgstatic.net/publication/336096674_One_piece_of_the_puzzle_Population_pharmacokinetics_of_FVIII_during_perioperative_Haemate_PRHumate_PR_treatment_in_von_Willebrand_disease_patients/links/5e57edb6299bf1bdb8408730/largepreview.png)
PDF) One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P®/Humate P® treatment in von Willebrand disease patients
![Haemate® P/Humate‐P® for the treatment of von Willebrand disease: considerations for use and clinical experience - AUERSWALD - 2008 - Haemophilia - Wiley Online Library Haemate® P/Humate‐P® for the treatment of von Willebrand disease: considerations for use and clinical experience - AUERSWALD - 2008 - Haemophilia - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2fd42114-5971-4405-a0f5-a780700c73ca/hae_1850_f2.gif)
Haemate® P/Humate‐P® for the treatment of von Willebrand disease: considerations for use and clinical experience - AUERSWALD - 2008 - Haemophilia - Wiley Online Library
![PDF) Safety and Efficacy of Continuous Infusion of a Combined Factor VIII – von Willebrand Factor (vWF) Concentrate (Haemate-P™) in Patients with von Willebrand Disease PDF) Safety and Efficacy of Continuous Infusion of a Combined Factor VIII – von Willebrand Factor (vWF) Concentrate (Haemate-P™) in Patients with von Willebrand Disease](https://i1.rgstatic.net/publication/13226652_Safety_and_Efficacy_of_Continuous_Infusion_of_a_Combined_Factor_VIII_-_von_Willebrand_Factor_vWF_Concentrate_Haemate-P_in_Patients_with_von_Willebrand_Disease/links/0a85e53ab8c9a03057000000/largepreview.png)
PDF) Safety and Efficacy of Continuous Infusion of a Combined Factor VIII – von Willebrand Factor (vWF) Concentrate (Haemate-P™) in Patients with von Willebrand Disease
![WO2008151817A1 - Use of vwf stabilized fviii preparations and of vwf preparations without fviii for extravascular administration in the therapy and prophylactic treatment of bleeding disorders - Google Patents WO2008151817A1 - Use of vwf stabilized fviii preparations and of vwf preparations without fviii for extravascular administration in the therapy and prophylactic treatment of bleeding disorders - Google Patents](https://patentimages.storage.googleapis.com/cc/4d/ef/7593f4f8f5cd52/imgf000037_0001.png)
WO2008151817A1 - Use of vwf stabilized fviii preparations and of vwf preparations without fviii for extravascular administration in the therapy and prophylactic treatment of bleeding disorders - Google Patents
Clinical use of Haemate® P in inherited von Willebrand's disease: a cohort study on 100 Italian patients | Haematologica
![WO2008151817A1 - Use of vwf stabilized fviii preparations and of vwf preparations without fviii for extravascular administration in the therapy and prophylactic treatment of bleeding disorders - Google Patents WO2008151817A1 - Use of vwf stabilized fviii preparations and of vwf preparations without fviii for extravascular administration in the therapy and prophylactic treatment of bleeding disorders - Google Patents](https://patentimages.storage.googleapis.com/18/16/36/c0799ff84d970c/imgf000031_0001.png)